FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2929422481> ?p ?o ?g. }

• W2929422481 endingPage "1300" @default.
• W2929422481 startingPage "1300" @default.
• W2929422481 abstract "5626 The t(4;14) translocation that occurs uniquely in a subset (15%) of multiple myeloma (MM) patients results in the ectopic expression of the receptor tyrosine kinase (RTK), FGFR3. Wild-type (WT) FGFR3 induces proliferative signals in MM cells and appears to be weakly transforming in a hematopoeitic mouse model. The subsequent acquisition of FGFR3 activating mutations in some MM is associated with disease progression and is strongly transforming in experimental models. The clinical impact of t(4;14) translocation has been demonstrated in 3 large studies each reporting a marked reduction in overall survival. We have previously shown that inhibition of activated FGFR3 causes morphologic differentiation followed by apoptosis of FGFR3 expressing MM cell lines, validating activated FGFR3 as a therapeutic target in t(4;14) MM and encouraging the clinical development of FGFR3 inhibitors for the treatment of these poor-prognosis patients. CHIR258 is a small molecule kinase inhibitor that targets Class III-V RTKs and inhibits FGFR3 with an IC 50 of 5 nM in vitro kinase assays. Potent anti-tumor and anti-angiogenic activity has been demonstrated in vitro and in vivo . We have employed the IL-6 dependent murine myeloma cell line, B9 that has been engineered to stably express either WT FGFR3 (B9-WT) or the K650E mutant FGFR3 (B9-TD) to screen CHIR258 for FGFR3 activity. CHIR258 inhibited FGF-mediated growth of B9-WT and B9-TD with an IC50 of 25nM and 80 nM respectively as determined by MTT assay. Growth of these cells could be rescued by IL-6 demonstrating selectivity of CHIR258 for FGFR3. At concentrations that prevented cell growth, CHIR258 inhibited in vitro FGFR3 autophosphorylation. We then confirmed the activity of CHIR258 against FGFR3 expressing MM cells. CHIR258 inhibited the growth of FGFR3 expressing KMS11 (Y373C), OPM2 (K650E), KMS18 (G384D) and H929 (WT FGFR3) cells with an IC 50 of 100 nM (KMS11 and OPM2 cells), 250 nM and 630 nM respectively. U266 cells, which lack FGFR3 expression, displayed minimal growth inhibition demonstrating that at effective concentrations, CHIR258 exhibits minimal nonspecific cytotoxicity on MM cells. Further characterization of this finding demonstrates that inhibition of cell growth is related to G1 cell cycle arrest and dose-dependent inhibition of ERK phosphorylation. CHIR258 also induced delayed, dose-responsive apoptosis of these cells . Apoptotic cells, assessed by annexin V staining, were detectable 2 (KMS11) and 5 (KMS18, OPM2) days after exposure to CHIR258 and increased with dose and days of treatment. Studies assessing in vivo activity of CHIR258 against FGFR3 expressing tumors in xenograft mice are ongoing and will be reported. These data indicate that the small molecule inhibitor, CHIR258 potently inhibits FGFR3 and has activity against human MM cells setting the stage for a Phase I/II clinical trial of this compound in t(4;14) MM." @default.
• W2929422481 created "2019-04-11" @default.
• W2929422481 creator A5008239781 @default.
• W2929422481 creator A5011332336 @default.
• W2929422481 creator A5019526963 @default.
• W2929422481 creator A5031779697 @default.
• W2929422481 creator A5040384208 @default.
• W2929422481 creator A5043044489 @default.
• W2929422481 creator A5068298685 @default.
• W2929422481 creator A5072749779 @default.
• W2929422481 creator A5082712392 @default.
• W2929422481 date "2004-04-01" @default.
• W2929422481 modified "2023-09-25" @default.
• W2929422481 title "Pre-clinical studies of CHIR258, a small molecule inhibitor that targets FGFR3, for the treatment of t(4;14) multiple myeloma" @default.
• W2929422481 hasPublicationYear "2004" @default.
• W2929422481 type Work @default.
• W2929422481 sameAs 2929422481 @default.
• W2929422481 citedByCount "0" @default.
• W2929422481 crossrefType "journal-article" @default.
• W2929422481 hasAuthorship W2929422481A5008239781 @default.
• W2929422481 hasAuthorship W2929422481A5011332336 @default.
• W2929422481 hasAuthorship W2929422481A5019526963 @default.
• W2929422481 hasAuthorship W2929422481A5031779697 @default.
• W2929422481 hasAuthorship W2929422481A5040384208 @default.
• W2929422481 hasAuthorship W2929422481A5043044489 @default.
• W2929422481 hasAuthorship W2929422481A5068298685 @default.
• W2929422481 hasAuthorship W2929422481A5072749779 @default.
• W2929422481 hasAuthorship W2929422481A5082712392 @default.
• W2929422481 hasConcept C101544691 @default.
• W2929422481 hasConcept C104317684 @default.
• W2929422481 hasConcept C121608353 @default.
• W2929422481 hasConcept C138626823 @default.
• W2929422481 hasConcept C147708747 @default.
• W2929422481 hasConcept C153911025 @default.
• W2929422481 hasConcept C170493617 @default.
• W2929422481 hasConcept C184235292 @default.
• W2929422481 hasConcept C190283241 @default.
• W2929422481 hasConcept C202751555 @default.
• W2929422481 hasConcept C203014093 @default.
• W2929422481 hasConcept C2776364478 @default.
• W2929422481 hasConcept C2778820342 @default.
• W2929422481 hasConcept C42362537 @default.
• W2929422481 hasConcept C502942594 @default.
• W2929422481 hasConcept C54355233 @default.
• W2929422481 hasConcept C55493867 @default.
• W2929422481 hasConcept C62478195 @default.
• W2929422481 hasConcept C74373430 @default.
• W2929422481 hasConcept C81885089 @default.
• W2929422481 hasConcept C86803240 @default.
• W2929422481 hasConcept C95444343 @default.
• W2929422481 hasConceptScore W2929422481C101544691 @default.
• W2929422481 hasConceptScore W2929422481C104317684 @default.
• W2929422481 hasConceptScore W2929422481C121608353 @default.
• W2929422481 hasConceptScore W2929422481C138626823 @default.
• W2929422481 hasConceptScore W2929422481C147708747 @default.
• W2929422481 hasConceptScore W2929422481C153911025 @default.
• W2929422481 hasConceptScore W2929422481C170493617 @default.
• W2929422481 hasConceptScore W2929422481C184235292 @default.
• W2929422481 hasConceptScore W2929422481C190283241 @default.
• W2929422481 hasConceptScore W2929422481C202751555 @default.
• W2929422481 hasConceptScore W2929422481C203014093 @default.
• W2929422481 hasConceptScore W2929422481C2776364478 @default.
• W2929422481 hasConceptScore W2929422481C2778820342 @default.
• W2929422481 hasConceptScore W2929422481C42362537 @default.
• W2929422481 hasConceptScore W2929422481C502942594 @default.
• W2929422481 hasConceptScore W2929422481C54355233 @default.
• W2929422481 hasConceptScore W2929422481C55493867 @default.
• W2929422481 hasConceptScore W2929422481C62478195 @default.
• W2929422481 hasConceptScore W2929422481C74373430 @default.
• W2929422481 hasConceptScore W2929422481C81885089 @default.
• W2929422481 hasConceptScore W2929422481C86803240 @default.
• W2929422481 hasConceptScore W2929422481C95444343 @default.
• W2929422481 hasLocation W29294224811 @default.
• W2929422481 hasOpenAccess W2929422481 @default.
• W2929422481 hasPrimaryLocation W29294224811 @default.
• W2929422481 hasRelatedWork W1973565962 @default.
• W2929422481 hasRelatedWork W1981102741 @default.
• W2929422481 hasRelatedWork W2120286630 @default.
• W2929422481 hasRelatedWork W2146758625 @default.
• W2929422481 hasRelatedWork W2228924732 @default.
• W2929422481 hasRelatedWork W2390316826 @default.
• W2929422481 hasRelatedWork W2511111668 @default.
• W2929422481 hasRelatedWork W2530792005 @default.
• W2929422481 hasRelatedWork W2538514347 @default.
• W2929422481 hasRelatedWork W2546469374 @default.
• W2929422481 hasRelatedWork W2558962826 @default.
• W2929422481 hasRelatedWork W2560139420 @default.
• W2929422481 hasRelatedWork W2562314043 @default.
• W2929422481 hasRelatedWork W2570328773 @default.
• W2929422481 hasRelatedWork W2581029351 @default.
• W2929422481 hasRelatedWork W2581181313 @default.
• W2929422481 hasRelatedWork W2583620316 @default.
• W2929422481 hasRelatedWork W2586123530 @default.
• W2929422481 hasRelatedWork W2967469044 @default.
• W2929422481 hasRelatedWork W3111143707 @default.
• W2929422481 hasVolume "64" @default.
• W2929422481 isParatext "false" @default.
• W2929422481 isRetracted "false" @default.

• next